Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Colombia

ABSTRACT: Background: Cutaneous leishmaniasis causes a high disease burden in Colombia, and available treatments present systemic toxicity, low patient compliance, contraindications, and high costs. The purpose of this study was to estimate the cost-effectiveness of thermotherapy versus Glucantime i...

Full description

Autores:
Cardona Arias, Jaiberth Antonio
López Carvajal, Liliana
Tamayo Plata, Mery Patricia
Vélez Bernal, Iván Darío
Tipo de recurso:
Article of investigation
Fecha de publicación:
2018
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/23077
Acceso en línea:
http://hdl.handle.net/10495/23077
Palabra clave:
Evaluación de Costo-Efectividad
Cost-Effectiveness Evaluation
Leishmaniasis Cutánea
Leishmaniasis, Cutaneous
Hipertermia Inducida
Hyperthermia, Induced
Colombia
Gluconato de Sodio Antimonio
Antimony Sodium Gluconate
Termoterapia
Thermotheraphy
Rights
openAccess
License
https://creativecommons.org/licenses/by/4.0/
id UDEA2_8388ce02b0616c2944b87786d89adf7c
oai_identifier_str oai:bibliotecadigital.udea.edu.co:10495/23077
network_acronym_str UDEA2
network_name_str Repositorio UdeA
repository_id_str
dc.title.spa.fl_str_mv Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Colombia
title Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Colombia
spellingShingle Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Colombia
Evaluación de Costo-Efectividad
Cost-Effectiveness Evaluation
Leishmaniasis Cutánea
Leishmaniasis, Cutaneous
Hipertermia Inducida
Hyperthermia, Induced
Colombia
Gluconato de Sodio Antimonio
Antimony Sodium Gluconate
Termoterapia
Thermotheraphy
title_short Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Colombia
title_full Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Colombia
title_fullStr Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Colombia
title_full_unstemmed Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Colombia
title_sort Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Colombia
dc.creator.fl_str_mv Cardona Arias, Jaiberth Antonio
López Carvajal, Liliana
Tamayo Plata, Mery Patricia
Vélez Bernal, Iván Darío
dc.contributor.author.none.fl_str_mv Cardona Arias, Jaiberth Antonio
López Carvajal, Liliana
Tamayo Plata, Mery Patricia
Vélez Bernal, Iván Darío
dc.contributor.researchgroup.spa.fl_str_mv Programa de Estudio y Control de Enfermedades Tropicales (PECET)
dc.subject.decs.none.fl_str_mv Evaluación de Costo-Efectividad
Cost-Effectiveness Evaluation
Leishmaniasis Cutánea
Leishmaniasis, Cutaneous
Hipertermia Inducida
Hyperthermia, Induced
Colombia
Gluconato de Sodio Antimonio
Antimony Sodium Gluconate
topic Evaluación de Costo-Efectividad
Cost-Effectiveness Evaluation
Leishmaniasis Cutánea
Leishmaniasis, Cutaneous
Hipertermia Inducida
Hyperthermia, Induced
Colombia
Gluconato de Sodio Antimonio
Antimony Sodium Gluconate
Termoterapia
Thermotheraphy
dc.subject.lemb.none.fl_str_mv Termoterapia
Thermotheraphy
description ABSTRACT: Background: Cutaneous leishmaniasis causes a high disease burden in Colombia, and available treatments present systemic toxicity, low patient compliance, contraindications, and high costs. The purpose of this study was to estimate the cost-effectiveness of thermotherapy versus Glucantime in patients with cutaneous leishmaniasis in Colombia. Methods: Cost-effectiveness study from an institutional perspective in 8133 incident cases. Data on therapeutic efficacy and safety were included, calculating standard costs; the outcomes were disability adjusted life years (DALYs) and the number of patients cured. The information sources were the Colombian Public Health Surveillance System, disease burden studies, and one meta-analysis of controlled clinical trials. Incremental cost-effectiveness was determined, and uncertainty was evaluated with tornado diagrams and Monte Carlo simulations. Results: Thermotherapy would generate costs of US$ 501,621; the handling of adverse effects, US$ 29,224; and therapeutic failures, US$ 300,053. For Glucantime, these costs would be US$ 2,731,276, US$ 58,254, and US$ 406,298, respectively. With thermotherapy, the cost would be US$ 2062 per DALY averted and US$ 69 per patient cured; with Glucantime, the cost would be US$ 4241 per DALY averted and US$ 85 per patient cured. In Monte Carlo simulations, thermotherapy was the dominant strategy for DALYs averted in 67.9% of cases and highly cost-effective for patients cured in 72%. Conclusion: In Colombia, thermotherapy can be included as a cost-effective strategy for the management of cutaneous leishmaniasis. Its incorporation into clinical practice guidelines could represent savings of approximately US$ 10,488 per DALY averted and costs of US$ 116 per additional patient cured, compared to the use of Glucantime. These findings show the relevance of the incorporation of this treatment in our country and others with similar parasitological, clinical, and epidemiological patterns.
publishDate 2018
dc.date.issued.none.fl_str_mv 2018
dc.date.accessioned.none.fl_str_mv 2021-10-10T03:13:48Z
dc.date.available.none.fl_str_mv 2021-10-10T03:13:48Z
dc.type.spa.fl_str_mv Artículo de investigación
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/ART
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
format http://purl.org/coar/resource_type/c_2df8fbb1
status_str publishedVersion
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/10495/23077
dc.identifier.doi.none.fl_str_mv DOI 10.1186/s12889-018-5060-2
dc.identifier.eissn.none.fl_str_mv 1471-2458
url http://hdl.handle.net/10495/23077
identifier_str_mv DOI 10.1186/s12889-018-5060-2
1471-2458
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartofjournalabbrev.spa.fl_str_mv BMC Public Health
dc.relation.citationendpage.spa.fl_str_mv 12
dc.relation.citationstartpage.spa.fl_str_mv 1
dc.relation.citationvolume.spa.fl_str_mv 18
dc.relation.ispartofjournal.spa.fl_str_mv BMC Public Health
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by/4.0/
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by/2.5/co/
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0/
http://creativecommons.org/licenses/by/2.5/co/
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.extent.spa.fl_str_mv 11
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv BMC
dc.publisher.place.spa.fl_str_mv Londres, Inglaterra
institution Universidad de Antioquia
bitstream.url.fl_str_mv https://bibliotecadigital.udea.edu.co/bitstreams/2b41f91c-dad0-4866-9b16-457fd16ecd4c/download
https://bibliotecadigital.udea.edu.co/bitstreams/c985eba7-c2e4-4727-8415-30307ccf77b2/download
https://bibliotecadigital.udea.edu.co/bitstreams/41fa1ed7-3115-4627-9866-ce0abd3f97fd/download
https://bibliotecadigital.udea.edu.co/bitstreams/ddf77f3f-c7ab-4e4f-af8a-fcbf3802dffa/download
https://bibliotecadigital.udea.edu.co/bitstreams/fe899be3-3cad-4ec6-8087-53fce7ba5649/download
bitstream.checksum.fl_str_mv 1646d1f6b96dbbbc38035efc9239ac9c
8a4605be74aa9ea9d79846c1fba20a33
ba05787a27d5d8c5aaa295d843c3e818
564a9ebfa0d950838ce2b7c2913e1229
18a1ae07eaa48d60524d6dfa1322500b
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional de la Universidad de Antioquia
repository.mail.fl_str_mv aplicacionbibliotecadigitalbiblioteca@udea.edu.co
_version_ 1851052559256518656
spelling Cardona Arias, Jaiberth AntonioLópez Carvajal, LilianaTamayo Plata, Mery PatriciaVélez Bernal, Iván DaríoPrograma de Estudio y Control de Enfermedades Tropicales (PECET)2021-10-10T03:13:48Z2021-10-10T03:13:48Z2018http://hdl.handle.net/10495/23077DOI 10.1186/s12889-018-5060-21471-2458ABSTRACT: Background: Cutaneous leishmaniasis causes a high disease burden in Colombia, and available treatments present systemic toxicity, low patient compliance, contraindications, and high costs. The purpose of this study was to estimate the cost-effectiveness of thermotherapy versus Glucantime in patients with cutaneous leishmaniasis in Colombia. Methods: Cost-effectiveness study from an institutional perspective in 8133 incident cases. Data on therapeutic efficacy and safety were included, calculating standard costs; the outcomes were disability adjusted life years (DALYs) and the number of patients cured. The information sources were the Colombian Public Health Surveillance System, disease burden studies, and one meta-analysis of controlled clinical trials. Incremental cost-effectiveness was determined, and uncertainty was evaluated with tornado diagrams and Monte Carlo simulations. Results: Thermotherapy would generate costs of US$ 501,621; the handling of adverse effects, US$ 29,224; and therapeutic failures, US$ 300,053. For Glucantime, these costs would be US$ 2,731,276, US$ 58,254, and US$ 406,298, respectively. With thermotherapy, the cost would be US$ 2062 per DALY averted and US$ 69 per patient cured; with Glucantime, the cost would be US$ 4241 per DALY averted and US$ 85 per patient cured. In Monte Carlo simulations, thermotherapy was the dominant strategy for DALYs averted in 67.9% of cases and highly cost-effective for patients cured in 72%. Conclusion: In Colombia, thermotherapy can be included as a cost-effective strategy for the management of cutaneous leishmaniasis. Its incorporation into clinical practice guidelines could represent savings of approximately US$ 10,488 per DALY averted and costs of US$ 116 per additional patient cured, compared to the use of Glucantime. These findings show the relevance of the incorporation of this treatment in our country and others with similar parasitological, clinical, and epidemiological patterns.COL001509911application/pdfengBMCLondres, Inglaterrahttps://creativecommons.org/licenses/by/4.0/http://creativecommons.org/licenses/by/2.5/co/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in ColombiaArtículo de investigaciónhttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARThttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionEvaluación de Costo-EfectividadCost-Effectiveness EvaluationLeishmaniasis CutáneaLeishmaniasis, CutaneousHipertermia InducidaHyperthermia, InducedColombiaGluconato de Sodio AntimonioAntimony Sodium GluconateTermoterapiaThermotheraphyBMC Public Health12118BMC Public HealthPublicationCC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8927https://bibliotecadigital.udea.edu.co/bitstreams/2b41f91c-dad0-4866-9b16-457fd16ecd4c/download1646d1f6b96dbbbc38035efc9239ac9cMD52falseAnonymousREADLICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstreams/c985eba7-c2e4-4727-8415-30307ccf77b2/download8a4605be74aa9ea9d79846c1fba20a33MD53falseAnonymousREADORIGINALJaiberthCardona_2018_Comprehensivethermotherapyleishmaniasis.pdfJaiberthCardona_2018_Comprehensivethermotherapyleishmaniasis.pdfArtículo de investigaciónapplication/pdf1237778https://bibliotecadigital.udea.edu.co/bitstreams/41fa1ed7-3115-4627-9866-ce0abd3f97fd/downloadba05787a27d5d8c5aaa295d843c3e818MD51trueAnonymousREADTEXTJaiberthCardona_2018_Comprehensivethermotherapyleishmaniasis.pdf.txtJaiberthCardona_2018_Comprehensivethermotherapyleishmaniasis.pdf.txtExtracted texttext/plain46723https://bibliotecadigital.udea.edu.co/bitstreams/ddf77f3f-c7ab-4e4f-af8a-fcbf3802dffa/download564a9ebfa0d950838ce2b7c2913e1229MD54falseAnonymousREADTHUMBNAILJaiberthCardona_2018_Comprehensivethermotherapyleishmaniasis.pdf.jpgJaiberthCardona_2018_Comprehensivethermotherapyleishmaniasis.pdf.jpgGenerated Thumbnailimage/jpeg14529https://bibliotecadigital.udea.edu.co/bitstreams/fe899be3-3cad-4ec6-8087-53fce7ba5649/download18a1ae07eaa48d60524d6dfa1322500bMD55falseAnonymousREAD10495/23077oai:bibliotecadigital.udea.edu.co:10495/230772025-03-27 00:18:45.682https://creativecommons.org/licenses/by/4.0/open.accesshttps://bibliotecadigital.udea.edu.coRepositorio Institucional de la Universidad de Antioquiaaplicacionbibliotecadigitalbiblioteca@udea.edu.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